Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib in Pemphigus Vulgaris
NCT03780166Phase 2Withdrawn
- Sponsor
- Incyte
- Start
- Mar 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of parsaclisib in pemphigus vulgaris (PV), sponsored by Incyte. Planned start Mar 2019; status: withdrawn.
02
Drugs
parsaclisib
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NCT03780166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780166.